Charming Medical Ltd

424B4 priced

8-A12B effective

Charming Medical Ltd filed a Form 8-A12B to register Class A Ordinary Shares on Nasdaq, referencing its previously effective F-1 registration statement (File No. 333-287258). The filing confirms the company's intent to list securities under Section 12(b) of the Exchange Act, with no exhibits required as the registration is not under Section 12(g).

CERT inactive

EFFECT effective

Charming Medical Ltd filed an amendment (Amendment No. 3) to its Form F-1 registration statement, adding Exhibit 23.1 and updating the exhibit index. The filing includes details on share reclassification, recent unregistered securities sales, and indemnification policies for directors/officers. It also references an underwriting agreement and legal opinions regarding corporate structure and tax matters.

F-1/A amended

Charming Medical Ltd's F-1/A filing represents an amendment to its initial registration statement, incorporating Exhibit 23.1 and updating the exhibit index. The filing details share reclassifications, including a 1:1,500 forward split, and recent private securities offerings. The company, based in the British Virgin Islands, operates in TCM-inspired wellness services and has undergone corporate restructuring, including the appointment of directors and executives. The filing also outlines indemnification provisions for directors and officers, as well as underwriting agreements for the IPO.

FWP supplemental

Range $4.00 to $6.00 · 1,600,000 shares · Gross proceeds $8,000,000

Charming Medical Ltd. is offering 1.6 million Class A ordinary shares in its initial public offering (IPO), with an estimated price range of $4 to $6 per share. The company, based in Hong Kong, provides TCM-inspired wellness and beauty services, including women's health, men's therapies, and franchise-based beauty outlets. Proceeds will fund business expansion, acquisitions, R&D, and working capital. The IPO is contingent on Nasdaq listing approval, with Cathay Securities, Inc. as the underwriter.

F-1/A amended

Range $4.00 to $6.00 · 1,600,000 shares

Charming Medical Ltd, a British Virgin Islands holding company, is conducting an IPO of 1.6 million Class A ordinary shares at an estimated price range of $4.00 to $6.00 per share. The offering is contingent on Nasdaq listing approval, with proceeds allocated to business expansion, strategic investments, R&D, and working capital. The company operates through Hong Kong subsidiaries and has a dual-class share structure, with Class A shares offering one vote and Class B shares 20 votes. The filing highlights risks related to PRC regulatory actions, operational dependencies, and challenges in enforcing legal rights against overseas directors.

FWP supplemental

Price $5.00 · Range $4.00 to $6.00 · 1,600,000 shares · Gross proceeds $8,000,000

Charming Medical Limited is conducting an initial public offering (IPO) of 1.6 million Class A ordinary shares at an estimated price range of $4 to $6 per share. The offering aims to raise up to $8 million, with proceeds allocated to business expansion, strategic acquisitions, R&D, and working capital. The company, operating through Hong Kong subsidiaries, provides TCM-influenced wellness and beauty services, combining traditional practices with modern therapies. The IPO is underwritten by Cathay Securities, Inc., and the shares are proposed to list on Nasdaq under the symbol MCTA.

F-1/A amended

Charming Medical Ltd. is conducting an initial public offering (IPO) of 1,600,000 Class A Ordinary Shares at an estimated price range of $4.00 to $6.00 per share. The shares will be listed on Nasdaq under the symbol 'MCTA,' contingent on approval. The company is a BVI holding company with operations in Hong Kong via subsidiaries. The offering includes a dual-class share structure, with Class A shares carrying one vote and Class B shares twenty votes. The filing emphasizes risks related to PRC regulatory actions, corporate structure, and uncertainties around overseas listings.

F-1 filed

Range $4.00 to $6.00 · 1,600,000 shares

Charming Medical Ltd, a British Virgin Islands holding company, is conducting an initial public offering (IPO) of 1,600,000 Class A ordinary shares at an estimated price range of $4.00 to $6.00 per share. The offering is contingent on listing on the Nasdaq Capital Market under the symbol 'MCTA.' The company operates through Hong Kong subsidiaries and faces regulatory risks due to its structure, including potential PRC government interventions. The IPO involves a dual-class share structure, with Class A shares carrying one vote and Class B shares 20 votes. The offering is subject to approval by the SEC and Nasdaq.

DRS/A amended

Charming Medical Ltd, a British Virgin Islands holding company, is conducting an initial public offering (IPO) of Class A ordinary shares, aiming to list on Nasdaq under the symbol 'MCTA'. The offering involves a dual-class share structure, with Class A shares representing 25% of the total shares post-offering. The company operates through Hong Kong subsidiaries and faces significant regulatory risks due to its structure and operations in Hong Kong, a special administrative region of China. The IPO is contingent on Nasdaq approval, and the company highlights risks related to PRC regulatory actions and corporate structure disallowance.

DRS/A amended

Charming Medical Ltd's DRS/A filing outlines an initial public offering (IPO) of Class A ordinary shares, with an anticipated price range of $[*] to $[*] per share. The offering is contingent on listing on Nasdaq under the symbol 'MCTA.' The company, a BVI holding company, operates through Hong Kong subsidiaries, facing risks related to PRC regulatory actions, cybersecurity reviews, and uncertainties in overseas listing approvals. The filing emphasizes heightened regulatory scrutiny of Chinese companies and potential impacts on operations and share value.

DRS filed

Charming Medical Ltd, a British Virgin Islands (BVI) holding company, is preparing for its initial public offering (IPO) of Class A ordinary shares on a firm commitment basis. The offering, subject to Nasdaq listing approval, involves a dual-class share structure with Class A shares (offered) and Class B shares (non-offered). The company operates through Hong Kong subsidiaries and faces risks related to PRC regulatory uncertainties, corporate structure limitations, and potential government interventions. The filing is a confidential draft under the JOBS Act, with no prior public filings.